TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29579158

Group type: EXPERIMENTAL
Intervention: Early BCG-Denmark
Number of subjects: 4172

Group type: COMPARATOR
Intervention: Control (local policy for LW and no BCG-Denmark)
Number of subjects: 4172
Study: 25529014

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HI-CT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Conventional-dose chemotherapy (CON-CT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)-only
Number of subjects: 83

Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 83
Study: 25276733

Group type: EXPERIMENTAL
Intervention: Mefenamic acid (3 times a day for 4 months)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vitex agnus castus (3 times a day for 4 months)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 84

Group type: COMPARATOR
Intervention: Vitex agnus
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mefenamic acid and Vitex agnus
Number of subjects: 84
Study: 21525683

Group type: EXPERIMENTAL
Intervention: Polylactic‐polyglycolic acids 50:50 (Fisiograft) alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Polylactic‐polyglycolic acids 50:50 in conjunction with polyglactin acid 910 (Vicryl Mesh)
Number of subjects: 40
Study: 18246387

Group type: EXPERIMENTAL
Intervention: IVC clamping
Number of subjects: 85

Group type: COMPARATOR
Intervention: IVC nonclamping
Number of subjects: 85
Study: 16428942

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus 5‐fluorouracil (PF)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Docetaxel plus 5‐fluorouracil (DF)
Number of subjects: 77
Study: 12782435

Group type: EXPERIMENTAL
Intervention: Diamorphine gel
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 13
Study: 11789275

Group type: EXPERIMENTAL
Intervention: Combined acupuncture‐isoflurane anesthesia (group II)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isoflurane anesthesia (group I)
Number of subjects: 42
Study: 9383135

Group type: EXPERIMENTAL
Intervention: Automated computer query with guideline reminder in charts of intervention providers
Number of subjects: 36

Group type: COMPARATOR
Intervention: No reminder in charts of control providers
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 1312233

Group type: EXPERIMENTAL
Intervention: Lisinopril + Hydrochlorothiazide (LIS + HCTZ)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Captopril + Hydrochlorothiazide (CAP + HCTZ)
Number of subjects: 175
Study: 3900906

Group type: EXPERIMENTAL
Intervention: Calf lung surfactant extract (3 mL, 90 mg) instilled into trachea before the first breath
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal saline (3 mL)
Number of subjects: 27
Study: 29721850

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus docetaxel (10 mg/kg and 75 mg/m2 every 3 weeks)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo plus docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Ramucirumab exposure (Cave,ss)
Number of subjects: 376
Study: 27055228

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using a 660-nm laser (200 mW, 6 J per point at 4 points) and an 810-nm laser (200 mW, 6 J per point at 3 points) applied on days 2 and 4 after surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (laser simulation)
Number of subjects: 40
Study: 24637789

Group type: EXPERIMENTAL
Intervention: Azilsartan 20 mg
Number of subjects: 700

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 700
Study: 23768024

Group type: EXPERIMENTAL
Intervention: Facet joint resection and L4-5 fusion
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Semilaminectomy and fusion
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Complete laminectomy and fusion
Number of subjects: 120
Study: 19897430

Group type: EXPERIMENTAL
Intervention: Asteame Nipple Guard™
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard gauze dressing
Number of subjects: 22
Study: 17943639

Group type: EXPERIMENTAL
Intervention: Desmopressin tablets 0.6 mg
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Desmopressin nasal spray 20 microg
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Desmopressin tablets and spray
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Desmopressin tablets
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Desmopressin tablets and nasal spray
Number of subjects: 154
Study: 16900609

Group type: EXPERIMENTAL
Intervention: RLAI
Number of subjects: 50
Study: 14674881

Group type: EXPERIMENTAL
Intervention: Neutralizing (experimental group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Distraction (control group)
Number of subjects: 29
Study: 12202502

Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PAL; add +1.50 D)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Single vision lenses (SV)
Number of subjects: 298
Study: 10344365

Group type: EXPERIMENTAL
Intervention: Automated peritoneal dialysis (APD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 36
Study: 8544145

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2202190

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Thiopentone-Isoflurane
Number of subjects: 41
Study: 7047170

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31039806

Group type: EXPERIMENTAL
Intervention: 15 mg of donepezil for 4 weeks before escalating to 23 mg (group 1)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: 10 mg and 23 mg on alternate days for 4 weeks prior to escalation (group 2)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Direct escalation to 23 mg (group 3)
Number of subjects: 175
Study: 27714945

Group type: EXPERIMENTAL
Intervention: Standard 40 Hz stimulation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Non-standard stimulation (500 Hz, 1200 Hz, burst)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All SCS settings (standard and non-standard)
Number of subjects: 29
Study: 26302879

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (no octreotide)
Number of subjects: 109
Study: 25213159

Group type: EXPERIMENTAL
Intervention: Medication plus supportive care
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Placebo plus supportive care
Number of subjects: 88

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 88
Study: 21946121

Group type: EXPERIMENTAL
Intervention: EUS‐CPB with triamcinolone and bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: EUS‐CPB with only bupivacaine (control)
Number of subjects: 40
Study: 19614878

Group type: EXPERIMENTAL
Intervention: Standardized nursing intervention protocol to minimize maternal-infant separation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 50
Study: 17565841

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided four points via one-puncture technique (Group U)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nerve stimulator-guided brachial plexus blocking (Group N)
Number of subjects: 80
Study: 14741163

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV vaccines
Number of subjects: 1497

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV vaccines with recombinant envelope subunit vaccine
Number of subjects: 1497
Study: 12487338

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (HII) involving feedback, a physician liaison, and quality improvement tools
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-intensity intervention (LII) with written feedback
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both interventions (HII and LII)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HII
Number of subjects: 32
Study: 10052667

Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion for 1 hour
Number of subjects: 8
Study: 7972815

Group type: EXPERIMENTAL
Intervention: Two-dimensional coronary MR angiography
Number of subjects: 20
Study: 2595645

Group type: EXPERIMENTAL
Intervention: Plasmion (gr P)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Haemaccel (gr H)
Number of subjects: 15
Study: 4422521

Group type: EXPERIMENTAL
Intervention: Masturbatory and coital stimuli
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Coital stimulus
Number of subjects: 60
Study: 31978593

Group type: COMPARATOR
Intervention: Cryoballoon ablation
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Contact force-guided radiofrequency ablation (CF-RF)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Both interventions (CF-RF and cryoballoon)
Number of subjects: 346
Study: 28689794

Group type: EXPERIMENTAL
Intervention: SQ grass sublingual immunotherapy tablet
Number of subjects: 812

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 812
Study: 26585118

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25335439

Group type: EXPERIMENTAL
Intervention: Web-based systematic review workflow platform (ReGroup)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paper
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile screening application (Screen2Go)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reference management software program (EndNote)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Web-based platform
Number of subjects: 0
Study: 23913463

Group type: EXPERIMENTAL
Intervention: SIELLO T steroid‐eluting ventricular leads
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: SIELLO JT steroid‐eluting atrial leads
Number of subjects: 139

Group type: COMPARATOR
Intervention: BPPU T non‐steroid leads
Number of subjects: 139

Group type: COMPARATOR
Intervention: BPPU JT non‐steroid leads
Number of subjects: 139
Study: 20567807

Group type: EXPERIMENTAL
Intervention: Proprioceptive cues validly cued (lateral force applied in the same direction as the visual target)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proprioceptive cues invalidly cued (lateral force applied in the opposite direction to the visual target)
Number of subjects: 0
Study: 18791166

Group type: EXPERIMENTAL
Intervention: Extended low-intensity anticoagulant therapy (INR 1.5-1.9)
Number of subjects: 661

Group type: COMPARATOR
Intervention: Conventional-intensity anticoagulant therapy (INR 2.0-3.0)
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Presence of factor V Leiden
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: 20210G>A prothrombin gene mutation
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Antithrombin deficiency
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Elevated factor VIII
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Elevated factor XI
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Elevated homocysteine
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Antiphospholipid antibody
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: One or more thrombophilic defects
Number of subjects: 661
Study: 16649864

Group type: EXPERIMENTAL
Intervention: Writing or talking about a negative experience for 15 min each during 3 consecutive days
Number of subjects: 319

Group type: COMPARATOR
Intervention: Thinking about a negative experience
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Writing about a positive experience (happiest day)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Replaying a positive experience (happiest day)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Analyzing the happiest moments
Number of subjects: 319

Group type: COMPARATOR
Intervention: Repetitively replaying the happiest moments
Number of subjects: 319
Study: 12579548

Group type: EXPERIMENTAL
Intervention: Self-administered psychosocial treatments (manual- and multimedia-based treatments)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-administered psychosocial treatments (inspirational literature and support groups)
Number of subjects: 0
Study: 10731864

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (1 mg/kg/d) (Group B)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Complementary food besides breast-feeding (Group A)
Number of subjects: 116
Study: 9209245

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 30 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 15 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 3 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 8141177

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) and prednisolone (P)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Cyclosporin (Cs) and prednisolone (P)
Number of subjects: 112
Study: 3527997

Group type: EXPERIMENTAL
Intervention: Arginine tidiacicate (ATCA) at a dose of 400 mg tablets three times a day for 30 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for 30 days
Number of subjects: 50
Study: 2659736

Group type: EXPERIMENTAL
Intervention: Cyclosporin (mean dose 7.2 mg/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporin (mean dose 5 mg/kg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 0
Study: 31047956

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (ACEi)
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB)
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: ACEi
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: ARB
Number of subjects: 624
Study: 28111466

Group type: EXPERIMENTAL
Intervention: Thalidomide/Bortezomib (TV)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Thalidomide (T)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Alfa‐2b interferon (alfa2‐IFN)
Number of subjects: 271
Study: 25468387

Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 23180178

Group type: EXPERIMENTAL
Intervention: THC/CBD spray
Number of subjects: 339

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study: 20957342

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Therapy (HBOT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 19559419

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE) with targeted biopsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard endoscopy with a 4-quadrant biopsy protocol
Number of subjects: 0
Study: 16912060

Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CRH
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12151445

Group type: EXPERIMENTAL
Intervention: Highly purified urinary FSH (150 IU starting dose)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg/day from day 5-10 of the ovarian cycle)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FSH after failure with CC
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CC followed by FSH if pregnancy not obtained
Number of subjects: 100
Study: 10631418

Group type: EXPERIMENTAL
Intervention: Reinforced Laryngeal Mask Airway (RLMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Laryngeal Mask Airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RLMA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both LMA and RLMA
Number of subjects: 60
Study: 8536775

Group type: EXPERIMENTAL
Intervention: Casodex 50 mg daily
Number of subjects: 245

Group type: COMPARATOR
Intervention: Castration (medical or surgical)
Number of subjects: 245
Study: 1943929

Group type: EXPERIMENTAL
Intervention: Patients referred from 24 hour medical centres
Number of subjects: 246

Group type: COMPARATOR
Intervention: General practitioners' referral letters
Number of subjects: 246
Study: 7025508

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 39
Study: 30897305

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg and caffeine 100 mg (FDC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ibuprofen lysinate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ibuprofen lysinate (postprandial)
Number of subjects: 36
Study: 28789559

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei NCC 2461 ST11 (1×10^9 cfu)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 26270341

Group type: EXPERIMENTAL
Intervention: Magnifying chromoendoscopy (MC)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 70
Study: 23113573

Group type: EXPERIMENTAL
Intervention: News frame: crime
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: News frame: economic contribution
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: News frame: crime with Moroccan origin
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Attitude to immigration
Number of subjects: 523
Study: 21705864

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 508

Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 508
Study: 18422814

Group type: EXPERIMENTAL
Intervention: Propranolol plus irbesartan (step-up dosage titration up to 300 mg/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Propranolol (20 mg b.i.d.) plus placebo
Number of subjects: 32
Study: 16495006

Group type: COMPARATOR
Intervention: Attention condition
Number of subjects: 223

Group type: COMPARATOR
Intervention: Distraction condition
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Self-report GI symptoms
Number of subjects: 223
Study: 12905101

Group type: EXPERIMENTAL
Intervention: 5 mg ritanserin
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 10 mg ritanserin
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 10803508

Group type: EXPERIMENTAL
Intervention: Initial systemic chemotherapy (prednisone, vincristine, doxorubicin, cyclophosphamide)
Number of subjects: 281
Study: 8628601

Group type: EXPERIMENTAL
Intervention: Antenatal phenobarbital (PB) therapy (10 mg/kg before delivery)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no PB therapy)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Antenatal phenobarbital (PB) therapy
Number of subjects: 96
Study: 1629092

Group type: EXPERIMENTAL
Intervention: Heating of the contralateral hand (60 degrees C) for 30 min before glucose intake
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no heating of the contralateral hand)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Heating of the contralateral hand (60 degrees C)
Number of subjects: 11
Study: 6338230

Group type: EXPERIMENTAL
Intervention: Wire-mesh element within the 'buzzer and pad' enuresis alarm device
Number of subjects: 0
Study: 31519779

Group type: EXPERIMENTAL
Intervention: Thrombolysis (IV tissue plasminogen activator)
Number of subjects: 121
Study: 29754812

Group type: EXPERIMENTAL
Intervention: Cardiac Contractility Modulation (CCM) for 24 weeks (n=74)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Continued medical therapy (control, n=86)
Number of subjects: 160
Study: 27010160

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Phenobarbital (PB)
Number of subjects: 200
Study: 25590178

Group type: EXPERIMENTAL
Intervention: Somatostatin 250μg bolus injection before ERCP and 250μg/hour intravenous infusion for 11 hours after ERCP
Number of subjects: 900

Group type: COMPARATOR
Intervention: No somatostatin treatments
Number of subjects: 900
Study: 22790176

Group type: EXPERIMENTAL
Intervention: VRET only
Number of subjects: 18

Group type: COMPARATOR
Intervention: VRET with cognitive therapy
Number of subjects: 18
Study: 20564068

Group type: EXPERIMENTAL
Intervention: 200 mg of oral modafinil daily
Number of subjects: 631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study: 18086100

Group type: EXPERIMENTAL
Intervention: Immediate circumcision (intervention arm)
Number of subjects: 4456

Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months (control arm)
Number of subjects: 4456
Study: 16301017

Group type: EXPERIMENTAL
Intervention: Psychological treatments (behavioural, cognitive-behavioural, cognitive)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14567294

Group type: EXPERIMENTAL
Intervention: Mouthwashing with tea tree oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xylitol
Number of subjects: 0
Study: 11023927

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 460

Group type: COMPARATOR
Intervention: Simvastatin placebo
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 460

Group type: COMPARATOR
Intervention: Enalapril placebo
Number of subjects: 460
Study: 10677983

Group type: EXPERIMENTAL
Intervention: 1% end‐tidal sevoflurane concentration in 66% nitrous oxide (group I n = 25)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 1.5% end‐tidal sevoflurane concentration in 66% nitrous oxide (group II n = 20)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 2% end‐tidal sevoflurane concentration in 66% nitrous oxide (group III n = 20)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Patients who moved at incision
Number of subjects: 65
Study: 1586064

Group type: EXPERIMENTAL
Intervention: Small droplet aerosol (3.2 microns MMD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Large droplet aerosol (5.2 microns MMD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Capsaicin aerosols
Number of subjects: 9